RevBio, Inc.
PrivateLast Round
Grant
Oct 6, 2023
Total Funding Raised
$14.8M
Company Overview
RevBio, Inc. is a clinical-stage medical device company developing a patented, synthetic, injectable, and osteoconductive bone adhesive biomaterial called TETRANITE® for use in dental and orthopedic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevBio, Inc. Comps
Public and private peers based on sector, stage, and business model.
RevBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 6, 2023 | ||||
| Grant | Sep 16, 2023 | ||||
| Grant | Jun 7, 2023 | ||||
| Strategic | Feb 14, 2023 | ||||
| Accelerator | Jun 7, 2022 | ||||
VC Round | Jun 11, 2021 |
Key People
Founding team and executive leadership
RevBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| MassChallenge | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2025
Monthly visitors increased 170% MoM, reaching 8.1K.
- May 2, 2025
Monthly visitors increased 367% MoM.
RevBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RevBio, Inc.'s valuation, stock price, and market status.
